Humans of AI3SD: Dr Jennifer Hiscock

Pauli, Michelle and Hiscock, Jennifer R. , Kanza, Samantha and Frey, Jeremy G. (eds.) (2021) Humans of AI3SD: Dr Jennifer Hiscock Southampton. University of Southampton 4pp. (doi:10.5258/SOTON/P0044).

Record type: Monograph (Project Report)

Abstract

This interview forms part of our Humans of AI3SD Series. Dr Jennifer Hiscock is a reader in supramolecular chemistry at the University of Kent and a UKRI Future Leaders fellow. Her research is focused on a new approach to antibiotic and anti-cancer drug design and she is also co-founder of an international Women in Supramolecular Chemistry network. In this Humans of AI3SD interview she discusses the marginalisation of women in chemistry, using AI to handle huge amounts of data, the power of interdisciplinary work and the surprising value of having an embedded social scientist on her team who encourages playing with watercolours, coloured pens and modelling clay!

Text

Humans_of_AI3SD_Interview-8-JH (2) - Version of Record

Available under License Creative Commons Attribution.

Download (293kB)

More information

Published date: 16 September 2021

Additional Information: Jennifer obtained her PhD from the University of Southampton (UK) under the supervision of Prof. Philip A. Gale in 2010 studying supramolecular host:guest chemistry. She continued her post-doctoral research between this group and Dstl (Porton Down – UK) until 2015 when she moved to the University of Kent (UK) as the Caldin research fellow. In 2016 she was awarded a permanent lectureship position at that same institution, which has since been followed by her promotion to Reader in Supramolecular Chemistry and Director of Innovation and Enterprise for the School of Physical Sciences in 2019. In 2020 she was awarded a UKRI Future Leaders Fellowship, developing novel cell surface active therapeutics and drug adjuvants. Her research currently focuses on an interdisciplinary approach to applying supramolecular chemistry to solve real-world problems.

Keywords: AI3SD, Interview

Learn more about Institute for Life Sciences research